Skip to main content

Market Overview

Mid-Day Market Update: Gold Rises 1.5%; Lyra Therapeutics Shares Plunge


Midway through trading Monday, the Dow traded down 0.41% to 30,093.04 while the NASDAQ rose 0.41% to 12,515.82. The S&P also fell, dropping 0.15% to 3,693.70.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 14,761,570 cases with around 282,320 deaths. India confirmed a total of at least 9,677,200 confirmed cases and 140,570 deaths, while Brazil reported over 6,603,540 COVID-19 cases with 176,940 deaths. In total, there were at least 67,170,830 cases of COVID-19 worldwide with over 1,537,780 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares climbed 0.6% on Monday. Meanwhile, top gainers in the sector included Perion Network Ltd. (NASDAQ: PERI), up 16%, and comScore, Inc. (NASDAQ: SCOR), up 9%.

In trading on Monday, energy shares fell 1.5%.

Top Headline

SEACOR Holdings (NYSE: CKH) agreed to be acquired by private equity firm American Industrial partners in an all-cash deal value at around $1 billion, including net debt.

AIP will commence a tender offer to acquire all SEACOR’s outstanding shares at $41.50 per share.


Equities Trading UP

Eastman Kodak Company (NYSE: KODK) shares shot up 56% to $11.73. There was no wrongdoing involved in the process of Eastman Kodak receiving a $765 million federal loan for its pharmaceuticals foray, the U.S. International Development Finance Corp. concluded.

Shares of Oncternal Therapeutics, Inc. (NASDAQ: ONCT) got a boost, shooting 70% to $4.52 after the company disclosed updated interim clinical data from the ongoing Phase 1/2 CIRLL clinical trial.

Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares were also up, gaining 85% to $10.29 after the company announced it launched an electric vehicle division.


Equities Trading DOWN

Globus Maritime Limited (NASDAQ: GLBS) shares tumbled 29% to $7.41 after the company reported a drop in Q3 earnings and sales. Globus Maritime also priced its 1.41 million unit public offering at $8.50 per share.

Shares of scPharmaceuticals Inc. (NASDAQ: SCPH) were down 32% to $5.93 after the company received Complete Response Letter from the FDA for FUROSCIX. The company said, 'In the CRL, the FDA cited their need to conduct pre-approval inspections at two of the company's third-party manufacturing facilities that could not be conducted due to travel restrictions.'

Lyra Therapeutics, Inc. (NASDAQ: LYRA) was down, falling 25% to $9.31 after the company said its topline results for LANTERN phase 2 in a randomized controlled study of its LYR-210 for the treatment of Chronic Rhinosinusitis did not reach its primary endpoint.


In commodity news, oil traded down 0.5% to $46.05, while gold traded up 1.5% to $1,868.40.

Silver traded up 2.1% Monday to $24.765 while copper fell 0.6% to $3.5030.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.2%, the Spanish Ibex Index fell 0.48%, while Italy’s FTSE MIB Index fell 0.33%. Meanwhile, the German DAX 30 dropped 0.22%, French CAC 40 fell 0.73% and London’s FTSE 100 gained 0.15%.

The UK’s house price index grew 7.6% year-over-year in November, while German industrial production rose 3.2% in October.



Data on consumer credit for October will be released at 3:00 p.m. ET. Analysts project consumer credit to increase $17.0 billion in October following September's $16.2 billion rise.


Related Articles (CKH + GLBS)

View Comments and Join the Discussion!

Posted-In: Mid-Day Market UpdateNews Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at